Celemics

Celemics Net Debt per Share

The Net Debt per Share of Celemics (331920.KQ) as of Oct 22, 2026 is -1,200.81 KRW. In the previous year, Net Debt per Share was -1,246.76 KRW — a change of -3.69% (higher).

Net Debt per Share

-1,200.81KRW

YoY

-3.69%

Last updated:

Net Debt per Share of Celemics is 2024 -1,200.81 KRW. Net Debt per Share of Celemics was 2023 -1,246.76 KRW. It decreases by -3.69% higher compared to the previous year.

The Celemics Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2017
926.23 KRW
Jan 1, 2018
1,315.48 KRW
Jan 1, 2019
-142.51 KRW
Jan 1, 2020
-3,165.50 KRW
Jan 1, 2021
-2,409.27 KRW
Jan 1, 2022
-1,463.61 KRW
Jan 1, 2023
-1,246.76 KRW
Jan 1, 2024
-1,200.81 KRW
The Celemics Net Debt per Share history
YEARNet Debt per ShareYoY
-1,200.81KRW-3.69%
-1,246.76KRW-14.82%
-1,463.61KRW-39.25%
-2,409.27KRW-23.89%
-3,165.50KRW+2,121.25%
-142.51KRW-110.83%
1,315.48KRW+42.02%
926.23KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Celemics Stock analysis

What does Celemics do? Celemics Inc is a South Korean company based in Seoul, operating within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company provides biotechnology services, focusing on the development and sale of target capture kit products. It also offers immune repertoire analysis solutions and next-generation sequencing solutions. Celemics Inc went public through an IPO on August 21, 2020, and currently employs 63 full-time staff. The company's products are sold in both domestic and international markets. Its headquarters are located in Seoul, South Korea, and it maintains a website at www.celemics.com. The firm's primary business activities include the provision of specialized biotechnology services, with an emphasis on innovative tools and solutions for life science research and applications. Celemics Inc has a presence in the Korean market and extends its reach to global customers, supporting various research and diagnostic needs through its technology-driven services. The company's operational focus remains on developing and delivering advanced biotechnology solutions to meet the evolving demands of the life sciences industry. Celemics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celemics stock

Net Debt per Share of Celemics is -1,200.81 KRW in 2024.

Net Debt per Share of Celemics changed from -1,246.76 KRW to -1,200.81 KRW, representing a -3.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Celemics since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Celemics

All Key Metrics — Celemics